Downregulation of EPAC1 in ovarian cancer cells greatly reduces phosphorylated protein kinase B (pAkt), cyclin D1, and cyclin-dependent kinase 4 (CDK4) signaling [144]. The gene discussed is RAPGEF3; the disease is ovarian carcinoma.